BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11854129)

  • 1. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Suematsu N; Kinugawa S; Ide T; Wen J; Takeshita A
    Circulation; 2002 Feb; 105(7):868-73. PubMed ID: 11854129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
    Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
    Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
    Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study.
    Nahrendorf M; Hu K; Hiller KH; Galuppo P; Fraccarollo D; Schweizer G; Haase A; Ertl G; Bauer WR; Bauersachs J
    J Am Coll Cardiol; 2002 Nov; 40(9):1695-700. PubMed ID: 12427425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin.
    Ihori H; Nozawa T; Sobajima M; Shida T; Fukui Y; Fujii N; Inoue H
    Heart Vessels; 2016 Aug; 31(8):1361-9. PubMed ID: 26686369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property.
    Matsuki A; Igawa A; Nozawa T; Nakadate T; Igarashi N; Nonomura M; Inoue H
    Circ J; 2006 Dec; 70(12):1643-9. PubMed ID: 17127814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats.
    Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Cao Y; Marutsuka K; Asada Y; Kangawa K; Eto T
    Circulation; 2004 Jul; 110(4):426-31. PubMed ID: 15262849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction.
    Bauersachs J; Galuppo P; Fraccarollo D; Christ M; Ertl G
    Circulation; 2001 Aug; 104(9):982-5. PubMed ID: 11524389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of myocardial infarct size by fluvastatin.
    Tiefenbacher CP; Kapitza J; Dietz V; Lee CH; Niroomand F
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H59-64. PubMed ID: 12623790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress.
    Kinugawa S; Tsutsui H; Hayashidani S; Ide T; Suematsu N; Satoh S; Utsumi H; Takeshita A
    Circ Res; 2000 Sep; 87(5):392-8. PubMed ID: 10969037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
    Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
    Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
    Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart.
    Obata T; Ebihara A; Yamanaka Y
    Biochim Biophys Acta; 2001 Apr; 1536(1):55-63. PubMed ID: 11335104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure.
    Peterson JT; Hallak H; Johnson L; Li H; O'Brien PM; Sliskovic DR; Bocan TM; Coker ML; Etoh T; Spinale FG
    Circulation; 2001 May; 103(18):2303-9. PubMed ID: 11342481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.
    Villarreal FJ; Griffin M; Omens J; Dillmann W; Nguyen J; Covell J
    Circulation; 2003 Sep; 108(12):1487-92. PubMed ID: 12952845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat.
    Zhou R; Xu Q; Zheng P; Yan L; Zheng J; Dai G
    Eur J Pharmacol; 2008 May; 586(1-3):244-50. PubMed ID: 18384769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.